Nice | Omalizumab for chronic urticaria

20th July 2015 by Louise Hudman

Nice | Omalizumab for chronic urticaria

This is a new guideline from Nice recommending that omalizumab can be considered in chronic urticaria.

Apparently it is already being used on occasion, though due to cost, it is more common for immunosuppressants like ciclosporin to be used. Omalizumab is preferred because of less need for monitoring.

It is not disease modifying and repeat courses are likely to be required.

Join

Join to view the rest of this content, as well as access all the benefits of joining NASGP.

Join

Login

Already a member? Login to view this content.

Login

"We’ve worked with the NASGP now for over a decade, and have always been impressed with their commitment to promoting a really productive working relationship between practices and GP locums, with the ultimate aim of making sure patients receive the best care, no matter which GP they see."

Lynda Cox, Practice Cover

Lynda Cox, Practice Cover

See the full list of features within our NASGP membership plans

Membership